Pipeline Assets
Underserved Dermatological Diseases
Not Specified (Early to Late-stage)Active
Key Facts
Indication
Underserved Dermatological Diseases
Phase
Not Specified (Early to Late-stage)
Status
Active
Company
About Leo Pharma
LEO Pharma is a long-established, private Danish pharmaceutical company with a singular focus on medical dermatology. The company is in a strong commercial phase, reporting a third consecutive year of double-digit revenue growth in 2025, a return to profitability, and positive free cash flow. Its strategy centers on advancing its pipeline in underserved dermatological areas, supporting external research through its Investigator Initiated Studies program, and building alliances to shape the future of skin disease treatment.
View full company profile